Binaytara, shared a post on LinkedIn:
“Update: Ivermectin and Cancer Treatment in 2026
With the National Cancer Institute now initiating preclinical research on ivermectin, the conversation around its role in cancer care is evolving—and getting louder.
But what do oncologists actually think right now?
In this updated analysis, we break down:
✔️ What’s new in ivermectin research
✔️ What cancer doctors are hearing from patients
✔️ Why experts remain cautious despite growing attention
The bottom line: while lab research continues, there is still no proven clinical benefit in cancer treatment.
Stay informed with the latest evidence and expert perspectives: here.”
Other articles featuring Binaytara on OncoDaily.